Actinogen Medical Ltd News

Actinogen Medical Ltd: ACW randomizes first US participant in Alzheimers trial

Dec 9, 2024 06:34

Actinogen Medical Ltd: ACW CMO presents academic poster at CTAD 2024 conference

Oct 31, 2024 11:49

Actinogen Medical Ltd: Actinogen appoints Andrew Udell as Chief Commercial Officer

Oct 29, 2024 05:56

Actinogen Medical Ltd: Listed Options Top 20 Holders

Sep 24, 2024 14:02

Actinogen Medical Ltd: Listed Options Distribution Schedule

Sep 24, 2024 14:02

Actinogen Medical Ltd: Trading Halt

Sep 16, 2024 09:55

Actinogen Medical Ltd: Pause in Trading

Sep 16, 2024 09:29

Actinogen Medical Ltd: Appendix 4G

Aug 30, 2024 07:16

Actinogen Medical Ltd: Corporate Governance Statement

Aug 30, 2024 07:15

Actinogen Medical Ltd: ACW updated depression trial results and implications

Aug 26, 2024 07:13

Actinogen Medical Ltd: ACW XanaCIDD phase 2a trial topline results

Aug 12, 2024 06:57

Actinogen Medical Ltd: Trading Halt

Aug 8, 2024 07:13

Actinogen Medical Ltd: ACW CMO presents academic poster at AAIC in Philadelphia

Jul 29, 2024 06:50

Actinogen Medical Ltd: ACW June 2024 quarterly activity report & Appendix 4C

Jul 22, 2024 07:28

Actinogen Medical Ltd: ACW XanaCIDD depression trial results expected early August

Jul 2, 2024 07:16

Actinogen Medical Ltd: Positive Xanamem biomarker trial published in Jnl Alz Dis

Jun 26, 2024 07:59

Actinogen Medical Ltd: Appendix 3Ys x 5

Jun 7, 2024 06:36

Actinogen Medical Ltd: ACW Clinical Trials Science Forum 23 May registration detail

May 13, 2024 06:56

Actinogen Medical Ltd: Trading Halt

May 1, 2024 07:26

Actinogen Medical Ltd: ACW March 2024 quarterly activity report & Appendix 4C

Apr 30, 2024 15:14